Diabetes & Metabolism Journal

Original Article

Basic and Translational Research
NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9: Xiaolong Li, Yan Cai, Zhu Zhong, Maolin Li, Dong Huang, Zhifei Qiao, Hongli Zhou, Zuo Zhang, Jiyin Zhou; Diabetes Metab J. 2026;50(1):47-61. Published online July 23, 2024; DOI: https://doi.org/10.4093/dmj.2023.0342

6,254 View
206 Download
2 Web of Science
6 Crossref

Background
Disorders of the blood-brain barrier (BBB) arising from diabetes mellitus are closely related to diabetic encephalopathy. Previous research has suggested that neuron-glia antigen 2 (NG2)-glia plays a key role in maintaining the integrity of the BBB. However, the mechanism by which NG2-glia regulates the diabetic BBB remains unclear.
Methods
Type 2 diabetes mellitus (T2DM) db/db mice and db/m mice were used. Evans-Blue BBB permeability tests and transmission electron microscopy techniques were applied. Tight junction proteins were assessed by immunofluorescence and transmission electron microscopy. NG2-glia number and signaling pathways were evaluated by immunofluorescence. Detection of matrix metalloproteinase-9 (MMP-9) in serum was performed using enzyme-linked immunosorbent assay (ELISA).
Results
In T2DM db/db mice, BBB permeability in the hippocampus significantly increased from 16 weeks of age, and the structure of tight junction proteins changed. The number of NG2-glia in the hippocampus of db/db mice increased around microvessels from 12 weeks of age. Concurrently, the expression of MMP-9 increased in the hippocampus with no change in serum. Sixteen- week-old db/db mice showed activation of the Wnt/β-catenin signaling in hippocampal NG2-glia. Treatment with XAV-939 improved structural and functional changes in the hippocampal BBB and reduced MMP-9 secretion by hippocampal NG2-glia in db/db mice. It was also found that the upregulation of β-catenin protein in NG2-glia in the hippocampus of 16-week-old db/db mice was significantly alleviated by treatment with XAV-939.
Conclusion
The results indicate that NG2-glia can lead to structural and functional disruption of the diabetic BBB by activating Wnt/β-catenin signaling, upregulating MMP-9, and degrading tight junction proteins.

Citations

Citations to this article as recorded by

Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment
Luyao Qiao, Xiaoping Tang, Jiaxing Peng, Qing Xie, Mengqian Wu, Xinyue Chen, Zhenyu Tang
Aging Clinical and Experimental Research.2026;[Epub] CrossRef
Potential role of ghrelin in neuroprotection and cognitive function: implications for diabetic cognitive impairment
Yuhan Zhang, Ruihua Zhang, Xin Wang, Leilei Shi, Hongzhe Zhu, Jiping Liu
PeerJ.2025; 13: e18898. CrossRef
Persisting blood–brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment
Roland Patai, Boglarka Csik, Adam Nyul-Toth, Rafal Gulej, Kiana Vali Kordestan, Siva Sai Chandragiri, Santny Shanmugarama, Stefano Tarantini, Peter Mukli, Anna Ungvari, Andriy Yabluchanskiy, Zoltan Ungvari, Anna Csiszar
GeroScience.2025; 47(3): 3835. CrossRef
Diabetes Differentially Alters Glial Cells in Different Brain Regions
Rashmi Kumari, Lisa Willing, Patricia J. McLaughlin
Diabetology.2025; 6(3): 16. CrossRef
Quetiapine Reverses the Behavior and Myelination in Alcohol-Exposed Gestational Diabetes Mellitus Offspring Mice via ERK1/2 Signaling
Dong Huang, Maolin Li, Zhifei Qiao, Hongli Zhou, Zuo Zhang, Jiyin Zhou
Biological and Pharmaceutical Bulletin.2025; 48(3): 323. CrossRef
Protection against stroke-induced blood-brain barrier disruption by Guanxinning injection and its active-component combination via TLR4/NF-κB/MMP9-mediated neuroinflammation
Siwen Fan, Hongying Du, Yixin Yao, Huanyi Wang, Min Zhang, Xuliu Shi, Jiankun Yan, Li Peng, Guangxu Xiao, Shuang He, Ming Lyu, Yan Zhu
Phytomedicine.2025; 147: 157162. CrossRef

Review

Pathophysiology
Primordial Drivers of Diabetes Heart Disease: Comprehensive Insights into Insulin Resistance: Yajie Fan, Zhipeng Yan, Tingting Li, Aolin Li, Xinbiao Fan, Zhongwen Qi, Junping Zhang; Diabetes Metab J. 2024;48(1):19-36. Published online January 3, 2024; DOI: https://doi.org/10.4093/dmj.2023.0110

17,575 View
436 Download
37 Web of Science
35 Crossref

Abstract PDF PubReader ePub

Insulin resistance has been regarded as a hallmark of diabetes heart disease (DHD). Numerous studies have shown that insulin resistance can affect blood circulation and myocardium, which indirectly cause cardiac hypertrophy and ventricular remodeling, participating in the pathogenesis of DHD. Meanwhile, hyperinsulinemia, hyperglycemia, and hyperlipidemia associated with insulin resistance can directly impair the metabolism and function of the heart. Targeting insulin resistance is a potential therapeutic strategy for the prevention of DHD. Currently, the role of insulin resistance in the pathogenic development of DHD is still under active research, as the pathological roles involved are complex and not yet fully understood, and the related therapeutic approaches are not well developed. In this review, we describe insulin resistance and add recent advances in the major pathological and physiological changes and underlying mechanisms by which insulin resistance leads to myocardial remodeling and dysfunction in the diabetic heart, including exosomal dysfunction, ferroptosis, and epigenetic factors. In addition, we discuss potential therapeutic approaches to improve insulin resistance and accelerate the development of cardiovascular protection drugs.

Citations

Citations to this article as recorded by

Interplay between cardiomyocytes and nonmyocytes plays a vital role in cardiac metabolism and function: early-phase metabolic syndrome and short QT
Belma Turan, Yasemin Atici, Deniz Billur
Canadian Journal of Physiology and Pharmacology.2026; 104: 1. CrossRef
Role of neddylation in diabetes metabolism: potential therapeutic target
Hui Li, Ruiyin Zeng, Jing Liu, Huiwen Wang
Journal of Diabetes & Metabolic Disorders.2026;[Epub] CrossRef
Biomarkers of Cardiac Metabolic Flexibility in Health, HFrEF and HFpEF
Hyeong Rok Yun, Manish Kumar Singh, Sunhee Han, Jyotsna S. Ranbhise, Joohun Ha, Sung Soo Kim, Insug Kang
International Journal of Molecular Sciences.2026; 27(2): 879. CrossRef
Association between free fatty acids and adverse outcomes in patients with and without diabetes undergoing percutaneous coronary intervention
Qinxue Li, Guyu Zeng, Deshan Yuan, Tianyu Li, Peizhi Wang, Ce Zhang, Sida Jia, Pei Zhu, Ying Song, Xiaofang Tang, Ping Liu, Yuejin Yang, Runlin Gao, Jingjing Xu, Xueyan Zhao, Jinqing Yuan
Journal of Translational Internal Medicine.2026; 14(1): 53. CrossRef
Lipid droplets beyond storage: Cellular metabolic modulator in the diabetic heart (Review)
Yongchun Liang, Xinbiao Fan, Xiaofei Geng, Yunfeng Jia, Wenyu Shang, Xitong Sun, Jun Ge, Guijun Ye, Boyu Zhu, Zheng Zhang, Yuxin Kang, Xiaoyu Shan, Junping Zhang
International Journal of Molecular Medicine.2026; 57(4): 1. CrossRef
From Metabolism to Mind: The Cardio–Metabolic–Brain Axis and the Role of Insulin Resistance—A Review
Joanna Cielecka, Zuzanna Szkamruk, Maciej Walędziak, Anna Różańska-Walędziak
Biomedicines.2026; 14(2): 394. CrossRef
Different Associations between Lipid Levels and Risk for Heart Failure according to Diabetes Progression
Seung-Hwan Lee, Kyu Na Lee, Jong-Chan Youn, Hun Sung Kim, Kyungdo Han, Mee Kyoung Kim
Diabetes & Metabolism Journal.2025; 49(1): 105. CrossRef
Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study
Elisa Russo, Francesca Viazzi, Roberto Pontremoli, Fabio Angeli, Carlo Maria Barbagallo, Bruno Berardino, Michele Bombelli, Federica Cappelli, Edoardo Casiglia, Rosario Cianci, Michele Ciccarelli, Arrigo F. G. Cicero, Massimo Cirillo, Pietro Cirillo, Lanf
Lipids in Health and Disease.2025;[Epub] CrossRef
Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias
Pegah Bahrami, Kelly A. Aromolaran, Ademuyiwa S. Aromolaran
Journal of Cellular Physiology.2025;[Epub] CrossRef
Cardiovascular abnormalities already occurred in newly-diagnosed patients with early-onset type 2 diabetes
Hong Lian, Qian Ren, Wei Liu, Rui Zhang, Xiantong Zou, Simin Zhang, Yingying Luo, Wei Deng, Qiuping Wang, Lin Qi, Yufeng Li, Wenbo Wang, Liyong Zhong, Pengkai Zhang, Chengcheng Guo, Li Li, Yating Li, Tianhao Ba, Chaochao Yang, Lili Huo, Yan’ai Wang, Chunx
Cardiovascular Diabetology.2025;[Epub] CrossRef
Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular-kidney-metabolic syndrome stages 0–4: evidence from a large cohort study
Fan-Shun Guo, Jia-Hao Dou, Jun-Xiang Wang, Chen Guo, Rui-Yun Wu, Xue-Lu Sun, Yi-Wei Hu, Jin Wei
Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Traditional Chinese medicine in the prevention of diabetes mellitus and cardiovascular complications: mechanisms and therapeutic approaches
Caixia Chen, Hui Gao, Ying Wei, Yaxi Wang
Frontiers in Pharmacology.2025;[Epub] CrossRef
Micronized Purified Flavonoid Fraction (Diosmin/Hesperidin) Ameliorates Cardiac Structural and Functional Integrity in Cisplatin-treated Male Wistar Rats by Modulating NLRP3/Caspase-1/-3 Signaling
W. A. Saka, P. A. Oyedokun, C. A. Adegbola, T. M. Akhigbe, P. J. Ashonibare, O. R. Kolawole, A. A. Oladipo, R. E. Akhigbe
Cell Biochemistry and Biophysics.2025; 83(4): 4415. CrossRef
Interaction between mitochondrial oxidative stress and myocardial fibrosis in the context of diabetes
Pu-Hua Zhang, Nuo-Nan Li, Xiang Gu, Chun-Xia Zhou, Zhen-Zhen Jiang, Xian-Jun Luo, Hong-Wen Zhu, Xiao-Yong Zhu
Frontiers in Endocrinology.2025;[Epub] CrossRef
Liposomal Nanoparticle Delivery of Ginkgo Flavone Glycosides Enhances SIRT1 Activation and Improves Diabetic Cardiomyopathy
Wei Gao, Ruoran Chen, Huixin Tong, Yu Wang, Linlang Liang, Yiyao Li, Hao Yu
International Journal of Nanomedicine.2025; Volume 20: 7295. CrossRef
A user-friendly sugar stevia: Role in diabetes-associated health adversities
Sanjay, Hae-Jeung Lee
Food Bioscience.2025; 71: 107121. CrossRef
Network pharmacology-based insights into the role of gut microbiota metabolites in insulin resistance
Bing Xiao, Xin Chen, Ruiyu Zong, Yiming Guan, Zhu Zhu, Siling Bi
Frontiers in Microbiology.2025;[Epub] CrossRef
Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular–kidney–metabolic (CKM) syndrome stages 0–3: a prospective cohort study of 282,920 participants in the UK Biobank
Kun Liu, Jinling Hu, Yueqing Huang, Dingliu He, Jing Zhang
Cardiovascular Diabetology.2025;[Epub] CrossRef
Frailty and depressive symptoms in relation to cardiovascular disease risk in middle-aged and older adults
Zheng Zhang, Huijie Xu, Runjia Zhang, Yangxinyu Yan, Xi Ling, Yun Meng, Xilin Zhang, Yuanyuan Wang
Nature Communications.2025;[Epub] CrossRef
Appetite adipokines and insulin resistance shape the link between sleep quality and cardiac structure in youths with cardiometabolic risk: the BCAMS study
Mengyu He, Ling Zhong, Lanwen Han, Xinghao Yi, Ming Li, Shan Gao
Cytokine.2025; 194: 156998. CrossRef
The association between TyG index and hypertension in middle-aged and elderly Chinese patients: Data from CHALRS
Jun Wang, Chao Tang, Zhijie Xie, Amirmohammad Khalaji
PLOS One.2025; 20(7): e0329234. CrossRef
C-reactive protein-triglyceride glucose index and heart failure in US adults from NHANES 2001–2010
Ningyi Cheng, Zhicheng Ma, Yukun Chen, Lei Jin, Liangwan Chen
Scientific Reports.2025;[Epub] CrossRef
The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study
Longyan Lv, Ping Zhang, Xuerui Chen, Yan Gao
Cardiovascular Diabetology.2025;[Epub] CrossRef
Dexamethasone-induced insulin resistance impaired artemin levels in the hippocampus and altered behavioural patterns
Hasan Çalışkan
Scripta Medica.2025; 56(6): 695. CrossRef
Arterial stiffness, cardiovascular disease and the risk of type 2 diabetes mellitus
A.A. Serhiyenko, M.E. Hotsko, V.V. Sulyma, V.A. Serhiyenko
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 21(5): 548. CrossRef
Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling
Xiao Zhang, Dong Xu, Rui Zhang, Hui Wang, Gangyi Yang
Osteoporosis International.2025; 36(12): 2401. CrossRef
Estimated glucose disposal rate predicts frailty through diabetes: Evidence from machine learning and mediation models in NHANES
Wentao Yang, Qian Cheng, Guoxin Huang, Hongming Lin, Yee Gary Ang
PLOS One.2025; 20(10): e0333388. CrossRef
Combined predictive value of triglyceride-glucose index and remnant cholesterol for coronary artery disease in young adults
Xi Wu, Mingxing Wu, Haobo Huang, Zhe Liu, He Huang, Lei Wang
Frontiers in Cardiovascular Medicine.2025;[Epub] CrossRef
Association between METS-IR and heart failure: a cross-sectional study
Xiaozhou Su, Chunli Zhao, Xianwei Zhang
Frontiers in Endocrinology.2024;[Epub] CrossRef
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance
Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Celestino Sardu, Luca Rinaldi, Vincenzo Russo, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso
International Journal of Molecular Sciences.2024; 25(15): 8369. CrossRef
The web of intrigue: unraveling the role of NETosis within the gut-microbiome-immune-heart axis in acute myocardial infarction and heart failure
Tai Yasuda, Kate Deans, Aditi Shankar, Robert Chilton
Cardiovascular Endocrinology & Metabolism.2024;[Epub] CrossRef
Relationship between the Mediterranean Diet and Vascular Function in Subjects with and without Increased Insulin Resistance
Marta Gómez-Sánchez, Leticia Gómez-Sánchez, Rocío Llamas-Ramos, Emiliano Rodríguez-Sánchez, Luis García-Ortiz, Ruth Martí-Lluch, María Cortés Rodríguez, Inés Llamas-Ramos, Manuel A. Gómez-Marcos
Nutrients.2024; 16(18): 3106. CrossRef
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, Yuxiang Wu, Junxia Min, Fudi Wang
Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef
The Role of Insulin Within the Socio-Psycho-Biological Framework in Type 2 Diabetes—A Perspective from Psychoneuroimmunology
Anne Wevers, Silvia San Roman-Mata, Santiago Navarro-Ledesma, Leo Pruimboom
Biomedicines.2024; 12(11): 2539. CrossRef
Targeting Cardiac Fibrosis in Diabetic Heart Failure: The Role of the EZH2, AMPK, and PPAR-γ Pathways (Diabetes Metab J 2024;48:716-29)
Jooyeop Lee, Joon Ho Moon
Diabetes & Metabolism Journal.2024; 48(6): 1176. CrossRef

First
Prev
Page of 1
Next
Last

Search